World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
61
Citations
10949
World Ranking
3729
National Ranking
148

Best Publications

  • Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

    Mark J. Millan

  • Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. I. A Multivariate Analysis of the Binding Profiles of 14 Drugs at 21 Native and Cloned Human Receptor Subtypes

    Mark J. Millan;Lisa Maiofiss;Didier Cussac;Valérie Audinot

  • Altering the course of schizophrenia: progress and perspectives

    Mark J. Millan;Annie Andrieux;George Bartzokis;Kristin Cadenhead

  • Improving the Treatment of Schizophrenia: Focus on Serotonin (5-HT)1A Receptors

    Mark J. Millan

  • Antinociceptive effects of mu- and kappa-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism.

    Christoph Stein;M.J. Millan;M.J. Millan;A. Yassouridis;A. Yassouridis;A. Herz;A. Herz

  • Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a []GTPγS binding study

    Adrian Newman-Tancredi;Samantha Gavaudan;Caroline Conte;Christine Chaput

  • Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.

    Mark J. Millan;Adrian Newman‐Tancredi;Valérie Audinot;Didier Cussac

  • The endocrinology of the opioids.

    Mark J. Millan;Albert Herz

  • Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor.

    Adrian Newman-Tancredi;Didier Cussac;Valérie Audinot;Jean-Paul Nicolas

  • Stress-induced release of brain and pituitary beta-endorphin: major role of endorphins in generation of hyperthermia, not analgesia.

    M.J. Millan;R. Przewlock;M. Jerlicz;Ch. Gramsch

  • Selective Blockade of Dopamine D3 Receptors Enhances while D2 Receptor Antagonism Impairs Social Novelty Discrimination and Novel Object Recognition in Rats: A Key Role for the Prefrontal Cortex

    David J G Watson;Florence Loiseau;Manuela Ingallinesi;Mark J Millan

  • Potentiation of the Fluoxetine-Induced Increase in Dialysate Levels of Serotonin (5-HT) in the Frontal Cortex of Freely Moving Rats by Combined Blockade of 5-HT1A and 5-HT1B Receptors with WAY 100,635 and GR 127,935

    A Gobert;J M Rivet;L Cistarelli;M J Millan

  • Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone

    Rudy Schreiber;Mauricette Brocco;Mark J. Millan

  • S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626.

    Mark J. Millan;Alain Gobert;Adrian Newman-Tancredi;Françoise Lejeune

  • Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors.

    A. Newman-Tancredi;C. Chaput;L. Verriele;M.J. Millan

  • S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.

    Millan Mj;Dekeyne A;Papp M;La Rochelle Cd

  • Expanding the repertoire of L-DOPA’s actions: A comprehensive review of its functional neurochemistry

    Philippe De Deurwaerdère;Giuseppe Di Giovanni;Giuseppe Di Giovanni;Mark J. Millan

  • α2‐Adrenergic Receptor Blockade Markedly Potentiates Duloxetine‐ and Fluoxetine‐Induced Increases in Noradrenaline, Dopamine, and Serotonin Levels in the Frontal Cortex of Freely Moving Rats

    A Gobert;J M Rivet;L Cistarelli;C Melon

  • Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535.

    Françoise Lejeune;Mark J. Millan

  • (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.

    Unknown

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Recently Published Articles